For instance, inhibition of KCNQ1OT1 by hsa-miR-140-3P exacerbates ischemia–reperfusion injury [44], and hsa-miR-140-3p inhibits cardiac hypertrophy through targeting Gata4 [45]. The gene discussed is GATA4; the disease is cardiac hypertrophy.